Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-12

FDA Approved: ZYNRELEF — Original Application (Heron Therapeutics, Inc.)

View source ↗

Summary

FDA approved ZYNRELEF, a fixed-dose combination of bupivacaine and meloxicam, for postoperative analgesia. The product combines a local anesthetic with an NSAID…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

ORIG AP for ZYNRELEF (BUPIVACAINE AND MELOXICAM)